Enhanced prehospital volume therapy does not lead to improved outcomes in severely injured patients with severe traumatic brain injury.


Journal

BMC emergency medicine
ISSN: 1471-227X
Titre abrégé: BMC Emerg Med
Pays: England
ID NLM: 100968543

Informations de publication

Date de publication:
23 01 2019
Historique:
received: 05 12 2017
accepted: 04 01 2019
entrez: 25 1 2019
pubmed: 25 1 2019
medline: 14 6 2019
Statut: epublish

Résumé

Whether enhanced prehospital volume therapy leads to outcome improvements in severely injured patients with severe traumatic brain injury (TBI) remains controversial. The aim of this study was to investigate the influence of prehospital volume therapy on the clinical course of severely injured patients with severe TBI. Data for 122,672 patients from TraumaRegister DGU A total of 169 patients per group fulfilled the inclusion criteria. Increasing volume administration was associated with reduced coagulation capability and reduced hemoglobin (Hb) levels (prothrombin ratio: group 1: 68%, group 2: 63.7%; p ≤ 0.04; Hb: group 1: 11.2 mg/dl, group 2: 10.2 mg/dl; p ≤ 0.001). It was not possible to show a significant reduction in the mortality rate with increasing volumes (group 1: 45.6, group 2: 45.6; p = 1). The data presented in this study demonstrates that prehospital volume administration of more than 1500 ml does not improve severely injured patients with severe traumatic brain injury (TBI).

Sections du résumé

BACKGROUND
Whether enhanced prehospital volume therapy leads to outcome improvements in severely injured patients with severe traumatic brain injury (TBI) remains controversial. The aim of this study was to investigate the influence of prehospital volume therapy on the clinical course of severely injured patients with severe TBI.
METHODS
Data for 122,672 patients from TraumaRegister DGU
RESULTS
A total of 169 patients per group fulfilled the inclusion criteria. Increasing volume administration was associated with reduced coagulation capability and reduced hemoglobin (Hb) levels (prothrombin ratio: group 1: 68%, group 2: 63.7%; p ≤ 0.04; Hb: group 1: 11.2 mg/dl, group 2: 10.2 mg/dl; p ≤ 0.001). It was not possible to show a significant reduction in the mortality rate with increasing volumes (group 1: 45.6, group 2: 45.6; p = 1).
CONCLUSIONS
The data presented in this study demonstrates that prehospital volume administration of more than 1500 ml does not improve severely injured patients with severe traumatic brain injury (TBI).

Identifiants

pubmed: 30674281
doi: 10.1186/s12873-019-0221-x
pii: 10.1186/s12873-019-0221-x
pmc: PMC6343344
doi:

Substances chimiques

Colloids 0
Crystalloid Solutions 0
Hemoglobins 0
Prothrombin 9001-26-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13

Références

Ann Surg. 2011 Feb;253(2):371-7
pubmed: 21178760
Eur J Trauma Emerg Surg. 2018 Apr;44(2):191-202
pubmed: 29079917
JAMA. 2006 Feb 22;295(8):919-24
pubmed: 16493105
Crit Care Med. 2003 Apr;31(4):1250-6
pubmed: 12682500
Ann Surg. 2006 Sep;244(3):371-80
pubmed: 16926563
Unfallchirurg. 2011 Aug;114(8):705-12
pubmed: 21152886
Isr Med Assoc J. 2004 Aug;6(8):485-9
pubmed: 15326830
J Neurosurg. 2014 Feb;120(2):434-46
pubmed: 24180566
Emerg Med Australas. 2011 Dec;23(6):665-76
pubmed: 22151665
Eur J Trauma Emerg Surg. 2009 Oct;35(5):437-47
pubmed: 26815209
World J Surg. 2007 Nov;31(11):2092-103
pubmed: 17899256
Prehosp Emerg Care. 2002 Oct-Dec;6(4):417-20
pubmed: 12385609
Emerg Med Serv. 2001 May;30(5):93-5, 96, 98 passim
pubmed: 11373917
J Emerg Trauma Shock. 2011 Oct;4(4):465-71
pubmed: 22090739
Unfallchirurg. 2004 Mar;107(3):203-10
pubmed: 14999368
J Trauma. 1995 Feb;38(2):185-93
pubmed: 7869433
Prehosp Disaster Med. 2005 Jul-Aug;20(4):228-34
pubmed: 16128470
Injury. 2012 Jul;43(7):1021-8
pubmed: 22487163
J Trauma. 2002 Jun;52(6):1141-6
pubmed: 12045644
Injury. 2015 Jan;46(1):4-9
pubmed: 25173671
Am J Emerg Med. 1994 Jan;12(1):36-42
pubmed: 8285969
J Trauma. 2008 Oct;65(4):748-54
pubmed: 18849786
Ann Emerg Med. 1993 Feb;22(2):225-6
pubmed: 8427436
Health Technol Assess. 2000;4(31):1-57
pubmed: 11109030
J Trauma. 2007 Dec;63(6):1338-46; discussion 1346-7
pubmed: 18212658
Biomed Res Int. 2015;2015:354367
pubmed: 25949995
Injury. 2009 Jan;40(1):11-20
pubmed: 19135193
J Anaesthesiol Clin Pharmacol. 2014 Jul;30(3):318-27
pubmed: 25190937
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Injury. 2013 May;44(5):611-7
pubmed: 22377276
Prehosp Emerg Care. 2002 Jan-Mar;6(1):81-91
pubmed: 11789657
Crit Care. 2012 Oct 18;16(5):R201
pubmed: 23078792
Neurocrit Care. 2015 Feb;22(1):34-44
pubmed: 25052157
Curr Opin Anaesthesiol. 1998 Apr;11(2):177-80
pubmed: 17013216

Auteurs

Bjoern Hussmann (B)

Trauma Surgery Department, Alfried Krupp Hospital, Alfried-Krupp-Str. 21, 45131, Essen, Germany. bjoern.hussmann@krupp-krankenhaus.de.

Carsten Schoeneberg (C)

Trauma Surgery Department, Alfried Krupp Hospital, Alfried-Krupp-Str. 21, 45131, Essen, Germany.

Pascal Jungbluth (P)

Department of Trauma and Hand Surgery, University Hospital, Duesseldorf, Germany.

Matthias Heuer (M)

Surgery Department, Philippusstift, Essen, Germany.

Rolf Lefering (R)

Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University, Witten, Germany.

Teresa Maek (T)

Trauma Surgery Department, Alfried Krupp Hospital, Alfried-Krupp-Str. 21, 45131, Essen, Germany.

Frank Hildebrand (F)

Clinic for Trauma and Reconstructive Surgery, University Hospital RWTH, Aachen, Germany.

Sven Lendemans (S)

Trauma Surgery Department, Alfried Krupp Hospital, Alfried-Krupp-Str. 21, 45131, Essen, Germany.

Hans-Christoph Pape (HC)

Department of Trauma, University Hospital and University of Zurich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH